Medical devices, healthcare technology and the business of care
510(k) clearance · K261014

Accuro 3S Needle Guide Kit

Rivanna Medical, Inc. · Decision date Jul 24, 2026

FDA DECISIONK261014

What did the FDA decide?

FDA records K261014 as a 510(k) premarket notification, with a decision dated Jul 24, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Radiology
Decision date
Jul 24, 2026

FDA source record

Regulatory record facts

Identifier
K261014
Regulatory pathway
510(k) premarket notification
Product code
ITX
Decision code
SESE
Decision date
Jul 24, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Transducer, Ultrasonic, Diagnostic.

Product code
ITX
FDA device class
2

FDA decision timeline

  1. K261014 received

    Application receipt date recorded by FDA.

  2. K261014 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code ITX

Product / regulatory recordCompanyPathwayDecision dateSource
CIVCO Medical Instruments Co., Inc.510(k) clearanceSep 24, 2026FDA
BA-004CCK261170
Fujifilm Corporation510(k) clearanceAug 12, 2026FDA
EM-TECH Solutions, Inc.510(k) clearanceAug 10, 2026FDA
UC-CARE , Ltd.510(k) clearanceJul 30, 2026FDA
Accurate Access, LLC510(k) clearanceJul 27, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Rivanna Medical, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Charlottesville, VA

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records